More M&A in Biotech Sector - Roche to acquire Promedior!

For those short-sighted investors who are selling their IMU shares at 5.5cents today ... take a look at the terms of Roche's acquisition just 4 days ago of Promedior:

Roche are paying an Upfront CASH payment of USD$300 million with contingent payments thereafter of up to USD$1 BILLION based on achieving certain milestones.

With CF33 & CheckVacc, HER-Vaxx, PD1-Vaxx all in human trials next year why on earth would you sell your IMU shares now????

Promedior Says To Be Acquired By Roche
Nov 15 (Reuters)

* PROMEDIOR ENTERS INTO DEFINITIVE MERGER AGREEMENT TO BE ACQUIRED BY ROCHE
* PROMEDIOR - TOTAL TRANSACTION VALUE OF UP TO $1.39 BILLION
* PROMEDIOR - UNDER TERMS OF MERGER AGREEMENT, ROCHE WILL MAKE UPFRONT CASH PAYMENT OF USD390MILLION
* PROMEDIOR - ROCHE WILL OBTAIN RIGHTS TO PROMEDIOR’S ENTIRE PORTFOLIO OF MOLECULES FOR SERIOUS FIBROTIC DISEASES, NOTABLY PRM-151
* PROMEDIOR - DEAL CONSIDERATION ALSO HAS ADDITIONAL CONTINGENT PAYMENTS OF UP TO $1 BILLION BASED ON ACHIEVEMENT OF CERTAIN MILESTONES